| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |